MKI67 and neoplasm: Tumours treated with combined USMB + HT (50 min) showed a further decrease in Ki-67 labeling indices to (0.24 ± 0.05%) (p≤0.05) at week 1, (0.13 ± 0.04%) (p≤0.05) at week 2, (0.20 ± 0.02%) (p≤0.05) at week 3 and (0.16 ± 0.05%) (p≤0.05) at week 4 compared to USMB.